Optical Drug Delivery
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
19
NCT06321562
Safety and Tolerability of a Timolol Releasing Intraocular Implant in Subjects With Primary Open-angle Glaucoma
Phase: Phase 1
Role: Lead Sponsor
Start: Mar 1, 2023
Completion: Jun 26, 2025
NCT07036510
Safety of TimoD Sustained-Release Implant in Participants With Glaucoma or Ocular Hypertension Undergoing Cataract Surgery
Start: Jun 12, 2025
Completion: Jan 31, 2027
Loading map...